Promethean’s Acquisition, HDT Bio’s $49M Funding, and More Seattle Tech News

Catch up on the latest Seattle tech news you may have missed last week.
Written by Cassidy Ritter
December 5, 2022Updated: December 5, 2022
Promethean CEO Vin Riera.
Promethean CEO Vin Riera. | Photo: Promethean

As we kick off the last month of 2022, Seattle tech companies are busy closing acquisitions and advancing their solutions. Catch up on the latest tech news with the Built In Seattle Weekly Refresh.

Promethean acquired Explain Everything. Seattle-based Promethean, an edtech company, acquired NYC-based Explain Everything. The NYC company developed a digital whiteboard platform that allows educators to create videos, draw and collaborate with others on the platform. The Explain Everything team will join Promethean, which is actively hiring for more than a dozen roles. [PR Newswire]

Seattle’s five largest funding rounds totaled $196.5M last monthBiopharmaceutical company Bonum Therapeutics raised the largest local tech funding round in November with a $93 million Series A. Other large rounds were raised by MotherDuck, Curevo, Gravitics and Notifi. [Built In Seattle]

Seattle Tech Quote of the Week

“Now more than ever, it’s vital we increase crypto literacy and help people understand the nuances of crypto, like how to self-custody and safely transact.” — Neil Bergquist, Coinme CEO and co-founder

Coinme and others released crypto literacy and education survey results. The second annual survey found that crypto literacy is improving and digital coin ownership is increasing. Compared to last years results, the survey found that 200 percent more participants plan to buy or sell crypto in the next six months. The study was released on Crypto Literacy’s website, an industry site promoting crypto education. The site is an initiative by Coinme with CoinDesk and MoneyGram participating. [PR Newswire]

HDT Bio got $49MFounded in 2018, HDT Bio is a biotech company that develops vaccines to prevent infectious diseases. The fresh capital is part of a project with the U.S. Department of Defense, U.S. Department of Health and Human Services and University of Texas to target deadly viruses that could impact military members. The funding will go toward early trials for vaccines for Crimean-Congo hemorrhagic fever and Nipah virus. [Puget Sound Business Journal]

Seattle startup guides

Best Companies to Work for in Seattle
Coolest Tech Offices in Seattle
Best Benefits at Seattle Tech Companies
Women in Seattle Tech